|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date10 Jun 1965 |
|
MechanismErgosterol modulators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CA |
First Approval Date01 Jan 1955 |
100 Clinical Results associated with CHARTWELL MOLECULES LLC
0 Patents (Medical) associated with CHARTWELL MOLECULES LLC
100 Deals associated with CHARTWELL MOLECULES LLC
100 Translational Medicine associated with CHARTWELL MOLECULES LLC